Similar researchers to Jean Costentin: Advanced Search
Name Institution Area Added by Date  
Lane J. Wallace (Info) Ohio State Neuropharmacology rtlayer 2014‑07‑02 Sim(0.57)
Nancy R. Zahniser (Info) University of Colorado, Denver addiction peris 2006‑09‑28 Sim(0.66)
Wouter Koek (Info) University of Texas Health Science Center at San Antonio tleegilman 2019‑02‑26 Sim(0.69)
Aaron Janowsky (Info) OHSU neurotransmitter transporter function and regulation, G-protein coupled receptors, receptor regulation, signal transduction systems, neuropsychiatric disorders, schizophrenia, addiction, methamphetamine, cocaine, pharmacotherapy development david 2015‑06‑18 Sim(0.79)
Billy R. Martin (Info) VCU Behavioral Pharmacology of Cannabinoids jerrywright 2009‑05‑28 Sim(0.82)
Glen R. Hanson (Info) University of Utah Pharmacology, Neuroscience Biology, Molecular Biology pq 2016‑05‑17 Sim(0.83)
Alan Cowan (Info) Temple University Pharmacology, Neuroscience Biology pq 2016‑05‑14 Sim(0.83)
Scott M. Rawls (Info) Temple University Glutamate, cannabinoids, opioids CJM3 2009‑03‑01 Sim(0.85)
Ian A. Paul (Info) University of Mississippi Medical Center antidepressants, glutamate, NMDA receptors, development, serotonin iapaul 2011‑06‑16 Sim(0.85)
Arvid Carlsson (Info) University of Göteborg Monoamine neurotransmission and pharmacology jpo 2006‑04‑17 Sim(0.86)
Toni Shippenberg (Info) NIDA Drug addiction hatejeda 2012‑08‑22 Sim(0.9)
Paul J. Fletcher (Info) Centre for Addiction and Mental Health fionadz 2015‑07‑02 Sim(0.9)
William L. Dewey (Info) VCU School of Medicine pharmacology, analgesics, opioids kmh83 2006‑12‑15 Sim(0.92)
Tsutomu SUZUKI (Info) kakuno 2020‑03‑25 Sim(0.94)
Jeffrey M. Witkin (Info) Eli Lilly rbcarter 2009‑05‑07 Sim(0.95)
GianLuigi Gessa (Info) Dept. Neuroscience, University of Cagliari Neuropsychopharmacology mrsdunn 2008‑09‑10 Sim(0.97)
Agu Pert (Info) NIH AndreaMele 2017‑04‑25 Sim(0.97)
Horace H. Loh (Info) UMN Opioid pharmacology CJM3 2009‑03‑23 Sim(0.97)
Dennis Paul (Info) LSU Health Sciences Center, New Orleans Pain pharmacology, cancer dpaul 2015‑12‑04 Sim(0.98)
C. David Marsden (Info) King's College (London) gersha 2018‑02‑16 Sim(0.99)
Richard A. Rabin (Info) SUNY Buffalo (MathTree) Pharmacology, Neuroscience Biology, Biostatistics Biology pq 2016‑03‑18 Sim(1)
John H. Kehne (Info) Neurogen CRF, GABA, psychopharmacology jas 2006‑10‑17 Sim(1)
James H. Woods (Info) University of Michigan behavioral pharmacology wfanteg 2006‑12‑19 Sim(1)
David Clark (Info) Univ of Wales Swansea addiction mgallow 2008‑10‑21 Sim(1.01)
Kenner C. Rice (Info) NIDA medicinal chemistry, drugs of abuse wfanteg 2010‑03‑30 Sim(1.02)
Lance R. McMahon (Info) University of Texas Health Science Center - San Antonio Behavioral pharmacology yoyo 2010‑04‑03 Sim(1.04)
Florence Noble (Info) CNRS & Université Paris Descartes lucaposa 2015‑10‑15 Sim(1.05)
Martin W. Adler (Info) Temple University Pharmacology, substance abuse CJM3 2009‑03‑01 Sim(1.06)
Georgianna G. Gould (Info) Syracuse (Evolution Tree) pq 2015‑10‑26 Sim(1.07)
Adam L. Halberstadt (Info) University of Pittsburgh Neuranatomy, Vestibular Neurophysiology pq 2015‑11‑06 Sim(1.08)
Brian M. Cox (Info) Uniformed Services University Opioid pharmacology CJM3 2009‑03‑01 Sim(1.09)
Jenny L. Wiley (Info) RTI International Behavioral Pharmacology jerrywright 2009‑04‑01 Sim(1.09)
Gary Gudelsky (Info) University of Cincinnati Neuropharmacology of amphetamines sunila14 2009‑08‑05 Sim(1.1)
Jonathan L. Katz (Info) NIDA Behavioral Pharmacology rbcarter 2009‑05‑11 Sim(1.11)
Phil Skolnick (Info) NIH anxiolytic drugs, GABA Receptors, glutamate, benzodiazepines, antidepressants, NMDA receptor iapaul 2014‑04‑21 Sim(1.11)
Louis S. Harris (Info) VCU School of Medicine Pharmacology, opioid, pain, analgesics kmh83 2006‑12‑21 Sim(1.13)
Stephan Hjorth (Info) Integrative Pharmacology, AstraZeneca R&D, Molndal, Sweden CNS, appetite, serotonin, cannabinoid, in vivo StephanHj 2006‑10‑20 Sim(1.14)
Vicki L. Coffin (Info) Ross University School of Medicine Adenosine, dopamine, dopamine D1 receptors, NK1 antagonist, muscarinic M2 antagonist, caffeine, adenosine antagonist Vlynn 2015‑04‑17 Sim(1.14)
Kathryn A. Cunningham (Info) UTMB Behavioral Neuroscience yoyo 2010‑04‑05 Sim(1.15)
Nigel T. Maidment (Info) UCLA chodge 2011‑10‑19 Sim(1.15)
Akira E. Takemori (Info) UMN Pain & Analgesia pinacrespo 2006‑09‑28 Sim(1.16)
Patrick M. Beardsley (Info) VCU drug abuse, behavioral pharmacology, rat/primate self administration vuncksa 2011‑10‑19 Sim(1.17)
Richard J. Bodnar (Info) CUNY Opioid System damani 2006‑08‑25 Sim(1.17)
Jan Kehr (Info) Karolinska Neuropharmacology kfrogg 2008‑12‑04 Sim(1.18)
Carol Paronis (Info) McLean Hospital, Harvard Medical School fmoura 2017‑12‑10 Sim(1.18)
Ana Maria Basso (Info) Abbott Labs Behavioral Neuroscience bassoam 2007‑10‑24 Sim(1.18)
Richard Thomas Layer (Info) InVivo Therapeutics Neuropharmacology, Spinal Cord Injury rtlayer 2014‑07‑02 Sim(1.18)
Ellen Unterwald (Info) Temple Univ Sch Med neuropharmacology mgallow 2008‑10‑20 Sim(1.18)
Linda P. Dwoskin (Info) University of Kentucky Drug and alcohol abuse CJM3 2009‑03‑15 Sim(1.19)
Jin-Chung Chen (Info) Chang-Gung University Drug addiction, Parkinson's disease, dopamine system Jinchen 2014‑05‑15 Sim(1.19)
Sign in to add a new person